Baxter (BAX) Tops Q2 EPS by 2c; raises guidance
Tweet
Share
E-mail
Get Alerts BAX Hot Sheet
Price: $23.68 --0%
Revenue Growth %: +2.5%
Financial Fact:
Cash dividends declared per common share: 0.13
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +2.5%
Financial Fact:
Cash dividends declared per common share: 0.13
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Baxter (NYSE: BAX) reported Q2 EPS of $0.68, $0.02 better than the analyst estimate of $0.66. Revenue for the quarter came in at $3.81 billion versus the consensus estimate of $3.75 billion.
GUIDANCE:
Baxter sees Q3 2024 EPS of $0.77-$0.79, versus the consensus of $0.74.
Baxter sees FY2024 EPS of $2.93-$3.01, versus the consensus of $2.92.
For earnings history and earnings-related data on Baxter (BAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cracker Barrel (CBRL) Tops Q4 EPS by 89c, Offers Guidance
- Annovis Bio partners with Weave Bio on AI platform for NDA filing
- Corcept names Justin Gunn president of endocrinology division
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
